Home LiteratureArticle Details
PMID: 19870170 Published · ppublish English Journal Article

MODIFICATION OF THE PATHOGENICITY OF PSEUDORABIES VIRUS BY ANIMAL PASSAGE.

The Journal of experimental medicine ·Vol. 57 ·No. 6 ·1933-05-31 ·Pages 925-31

Shope RE

Abstract

Pseudorabies virus, Iowa strain ("mad itch"), after passage through guinea pig brain, fails to produce infection in guinea pigs when injected subcutaneously unless enormous doses are employed. Such virus is still pathogenic for rabbits when given subcutaneously and for rabbits and guinea pigs intracerebrally. Comparison of the amounts of virus present in the brains of rabbits and guinea pigs following fatal cerebral infection shows that the latter contain, per gram, only approximately one-tenth the amount of virus in the former. Comparing the resistance of the two species to subcutaneously administered pseudorabies virus it has been found that rabbits are approximately 100 times more susceptible than guinea pigs. Over and above the working of these two factors, guinea pig passage appears to achieve some actual attenuation of virus when tested by subcutaneous inoculation into guinea pigs.

Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Shope R E
Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, N. J.
References (1)
1 references, click to expand
  1. AN EXPERIMENTAL STUDY OF "MAD ITCH" WITH ESPECIAL REFERENCE TO ITS RELATIONSHIP TO PSEUDORABIES.
    J Exp Med. 1931 Jul 31;54(2):233-48 PMID: 19869913
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1933-05-31
Pages
925-31
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2132273
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com